1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

  • June 2020
  • 184 pages
  • ID: 5932697
  • Format: PDF
  • The Insight Partners
Up to $1710 off Until Mar 10th 2021


Table of Contents

Search Inside

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027.

Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously.Several pharmaceutical and medical device companies have developed wearable injectors.

The devices consist of a reservoir for medicine, a cannula for substance delivery to tissues, and a drive system to deliver the appropriate drug volume; it is loaded with adhesive to fix the device to the patients’ skin.The growth of the wearable injector market is attributed to the increasing chronic disease prevalence, technological advancements and design development, and conventional drug delivery system limitations, among others.

However, the lack of adoption in emerging countries limits the market growth. Further, the increasing demand for biologics is a significant opportunity for the global wearable injectors market players.

Lucrative Regional Wearable Injectors Markets

Market Insights

Technological Advancements and Design Development

Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering a high volume of viscous formulations.The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings.

Self-administration of subcutaneous injections is expected to save 30-70% of costs.Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries.

The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices.Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors.

For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and more significant volume capabilities to its high-volume wearable injectors.
A new category of wearable products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life.One such example is Stevanato Group’s cartridge-based wearable device, currently under development, received Best Innovation in Drug Delivery Device award at Pharmapack Awards in 2019.

The product includes a disposable, wearable pod, and reusable handheld controller that serves as the user interface and control unit for the pod.This is used for varied therapeutic areas, including diabetes, hormone therapies, pain management, and Alzheimer’s disease treatment.

Moreover, continuous development by leading players in upgrading the existing wearable injector portfolio is further driving the demand for wearable injectors.For instance, in February 2020, BD, a leading global medical technology company, completed a human clinical trial of the BD Libertas Wearable Injector.

The award-winning injector is currently in development and is designed as a subcutaneous drug delivery system to deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.

Products Insights
Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors.In 2019, the on-body injectors segment accounted for a larger share of the global wearable injectors market.

On-body injectors ensure comfort and ease of use, confer water resistance and flexible dosing features, and facilitate automatic warming of refrigerated drugs.These benefits have led to the rise in demand for on-body injectors.

Moreover, the market for off-body injectors is expected to grow at a faster pace during the forecast period, and the projected growth is attributed to the fact that these devices are free of the risks of skin fitting issues and allergic skin reactions.

End User Insights

Based on end user, the wearable injectors market is segmented into hospitals and clinics, homecare setting, and other end users.The homecare setting segment held the largest share in the global wearable injectors market in 2019.

Growth of the market for this segment is attributed to expose to global trends, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations.For instance, the home care segment is anticipated to dominate the market due to the growing inclination toward self-administration of medicine and the rising preference of low-cost healthcare procedures.

Also, the increasing demand for technologically developed drug delivery options to lowers the frequency of hospital visits and requires minimal expertise.Moreover, the ease of use, and ready availability and accessibility has also increased the adoption of wearable injectors among patients.

Hence, this has increased the use of drug delivery systems in in-home care settings.

Strategic Insights

Collaborations and technology partnerships by the players operating in the market to bridge the demand-supply gap are anticipated to play a significant role in the growth of the wearable injectors market during the forecast period. Moreover, the growing number of accidents and trauma cases, and rising incidence of infectious diseases are predicted to accelerate market growth.

By Type
• On-body Injectors
• Off-body Injectors
By Application
• Diabetes
• Oncology
• Cardiovascular Disease
• Autoimmune Disease
• Other Applications
By End User
• Hospitals and Clinics
• Homecare Setting
• Other End User
By Geography
• North America
o US
o Canada
o Mexico
• Europe
o France
o Germany
o Italy
o UK
o Russia
o Rest of Europe
• Asia Pacific (APAC)
o China
o India
o South Korea
o Japan
o Australia
o Rest of Asia Pacific
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of Middle East and Africa
• South and Central America (SCAM)
o Brazil
o Argentina
o Rest of South America

Company Profiles
• Amgen, Inc.
• Medtronic
• BD
• Insulet Corporation
• Gerresheimer AG (Sensile Medical)
• West Pharmaceutical Services, Inc.
• Ypsomed AG,
• Tandem Diabetes Care, Inc.
• Cequr SA
• Debiotech S.A
• E3D Elcam Drug Delivery Devices
• Zealand Pharma A/S (Valeritas, Inc.)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Organoids Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type ; Application ; Source, and Geography

  • $ 4500
  • January 2021
  • 174 pages

The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand fo ...

  • World
  • APAC
  • Pathology
  • Infectious Disease
  • Industry analysis
  • Health Expenditure
  • Mortality Rate


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on